Kiora Pharmaceuticals Inc.

KPRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.68

-$0.08 (-2.90%)

At close: Sep 21, 2026, 4:00 PM ET

$2.69

+$0.01 (+0.37%)

After-hours: Sep 21, 2026, 5:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	41.98K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.94K	n/a	n/a	n/a	10.29K	n/a	n/a	n/a	59.5K	n/a	n/a	n/a
Gross Profit	n/a	-41.98K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16M	-7.94K	n/a	n/a	n/a	-10.29K	n/a	n/a	n/a	-59.5K	n/a	n/a	n/a
Operating Income	n/a	-2.5M	-7.31M	-794.44K	-2.4M	-2.33M	-2.56M	-3.6M	-2.54M	13.22M	-1.99M	-5.92M	-2.63M	-1.92M	-2.66M	-3.7M	-2.4M	-3.57M	-2.29M	-3.04M	-2.82M	-2.01M
Interest Income	n/a	139.34K	190.31K	201.82K	225.24K	276.63K	438.86K	248.84K	342.1K	223.05K	45.53K	49.91K	45.09K	33.47K	38.98K	7.86K	1.24K	217	300	259	332	250
Pretax Income	-2.08M	-2.42M	-7.17M	-616.32K	-2.26M	-2.07M	-2.16M	-3.41M	-2.22M	13.45M	-2.18M	-5.76M	-2.61M	-1.87M	-2.61M	-5.12M	-2.4M	-3.57M	-5.95M	-3.03M	-2.54M	-2.01M
Net Income	-2.08M	-2.42M	-6.52M	26.81K	-2.15M	-2.19M	-4.22M	-3.41M	-2.22M	13.45M	-2.27M	-5.76M	-2.61M	-1.87M	-2.5M	-5.12M	-2.4M	-3.57M	-5.75M	-3.03M	-2.54M	-2.01M
Selling & General & Admin	1.38M	1.61M	1.46M	1.44M	1.35M	1.49M	1.33M	1.38M	1.54M	1.3M	872.62K	1.42M	1.1M	1.27M	1.8M	2.03M	1.8M	1.66M	1.23M	1.34M	1.31M	1.3M
Research & Development	2.08M	2.12M	1.17M	1.07M	904.57K	565.76K	1.18M	1.32M	906.68K	1.68M	1.11M	1.09M	1.39M	438.28K	841.62K	1.33M	567.23K	707.93K	1M	1.63M	1.44M	1.28M
Other Expenses	n/a	-1.28M	4.68M	-1.72M	137.78K	275.19K	58.48K	904.01K	100.23K	-202.75K	n/a	3.42M	143.62K	208.93K	n/a	337.52K	32.94K	1.2M	n/a	68.01K	73.72K	-570.2K
Operating Expenses	3.46M	2.46M	7.31M	794.44K	2.4M	2.33M	2.56M	3.6M	2.54M	2.78M	1.98M	5.92M	2.63M	1.92M	2.65M	3.7M	2.4M	3.57M	2.23M	3.04M	2.82M	2.01M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	21.45K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.13K	n/a	2.03K	686
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	2.5M	7.31M	794.44K	2.4M	2.33M	2.56M	3.6M	2.54M	2.78M	1.99M	5.92M	2.63M	1.92M	2.66M	3.7M	2.4M	3.57M	2.29M	3.04M	2.82M	2.01M
Income Tax Expense	n/a	n/a	-649.97K	-643.13K	-112.06K	123.01K	2.07M	n/a	n/a	n/a	90.32K	n/a	n/a	n/a	-113.01K	n/a	n/a	n/a	-192.6K	n/a	n/a	n/a
Shares Outstanding (Basic)	6.18M	4.17M	4.17M	4.29M	3.99M	4.22M	3M	4.21M	4.17M	25.94M	7.71M	7.11M	3.29M	1.86M	1.8M	848.53K	326.64K	316.38K	256.63K	256.63K	186.66K	183.95K
Shares Outstanding (Diluted)	6.18M	4.17M	4.1M	4.36M	3.99M	4.22M	3M	4.21M	4.17M	35.03M	7.71M	7.11M	3.29M	1.86M	1.8M	848.53K	326.64K	326.47K	256.63K	267.59K	186.66K	183.95K
EPS (Basic)	-0.34	-0.58	-1.55	0.01	-0.54	-0.52	-1.41	-0.81	-0.53	4.67	-0.29	-0.81	-0.79	-1.20	-1.52	-7.70	-7.35	-11.25	-32.65	-11.56	-13.23	-14.03
EPS (Diluted)	-0.34	-0.58	-1.59	0.01	-0.54	-0.52	-1.41	-0.81	-0.53	3.46	-0.29	-0.81	-0.79	-1.20	-1.52	-7.70	-7.35	-10.91	-32.65	-11.09	-13.23	-14.03
EBITDA	n/a	-2.38M	-5.26M	-2.5M	-2.25M	-2.05M	-2.4M	-2.7M	-2.42M	13.21M	-2.17M	-2.49M	-2.47M	-1.7M	-2.6M	-3.36M	-2.36M	-2.36M	-5.88M	-2.96M	-2.53M	-2M
EBIT	n/a	-2.42M	-5.27M	-2.52M	-2.26M	-2.06M	-2.41M	-2.7M	-2.42M	13.21M	-2.18M	-2.5M	-2.49M	-1.71M	-2.61M	-3.37M	-2.37M	-2.37M	-5.94M	-2.97M	-2.54M	-2.01M
Depreciation & Amortization	n/a	41.98K	10.51K	10.55K	3.42K	318	5.91K	2.1K	6.33K	4.87K	7.94K	11.31K	22.48K	10.08K	10.29K	10.27K	10.28K	10.77K	59.5K	11.06K	12.6K	10.6K